BioArctic
BioArctic Q1: Building value and diversifying (Redeye)

2021-04-21 12:45
Redeye's positive view on BioArctic was strengthened after today's Q1 report. The company continues to build value in the portfolio and diversify, thus reducing risk. We are confident in BioArctic's long-term capability to innovate and create value for all stakeholders.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

BioArctic B - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -